Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress-Reference-Cited by-同舟云学术

Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress

Published:2011-06 Issue:2 Volume:229 Page:450-459
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Lee Choong Hyun,Park Joon Ha,Yoo Ki-Yeon,Choi Jung Hoon,Hwang In Koo,Ryu Pan Dong,Kim Do-Hoon,Kwon Young-Guen,Kim Young-Myeong,Won Moo-Ho

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference46 articles.

1. Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice;Aggarwal;Life Sci.,2010

2. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability;Anderson;Depress. Anxiety,1998

3. Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils;Candelario-Jalil;Neurosci. Res.,2003

4. Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia;Chan;Neurochem. Res.,2004

5. Early-life fluoxetine exposure reduced functional deficits after hypoxic-ischemia brain injury in rat pups;Chang;Neurobiol. Dis.,2006

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics;Frontiers in Immunology;2023-10-10

2. Therapeutic effects of exercise-accompanied escitalopram on synaptic potency and long-term plasticity in the hippocampal CA1 area in rats under chronic restraint stress;IRAN J BASIC MED SCI;2022

3. Role of Thioredoxin-1 and its inducers in human health and diseases;European Journal of Pharmacology;2022-03

4. Chronic Antidepressant Use;Journal of Reports in Pharmaceutical Sciences;2022-01

5. The 5-HT1A receptor as a serotonergic target for neuroprotection in cerebral ischemia;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2021-07